Tezosentan (an intravenous endothelin receptor A/B antagonist) reduces peripheral resistance and increases cardiac power therefore preventing a steep decrease in blood pressure in patients with congestive heart failure.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples